Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.5 GBX | 0.00% | -1.35% | -12.05% |
Sales 2024 * | 44.55B 405M 556M | Sales 2025 * | 50.49B 459M 630M | Capitalization | 53.09B 483M 663M |
---|---|---|---|---|---|
Net income 2024 * | 5.13B 46.67M 64.05M | Net income 2025 * | 6B 54.56M 74.88M | EV / Sales 2024 * | 1.33 x |
Net Debt 2024 * | 5.99B 54.5M 74.8M | Net Debt 2025 * | 884M 8.04M 11.03M | EV / Sales 2025 * | 1.07 x |
P/E ratio 2024 * |
9.67
x | P/E ratio 2025 * |
7.88
x | Employees | 5,700 |
Yield 2024 * |
3.36% | Yield 2025 * |
4.2% | Free-Float | 76.68% |
1 week | -1.35% | ||
Current month | -6.41% | ||
1 month | -2.67% | ||
6 months | -6.41% | ||
Current year | -12.05% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 61 | 89-12-31 | |
Chief Tech/Sci/R&D Officer | - | - | |
Selina Akter
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 75-12-31 | |
Founder | - | 75-12-31 | |
Iqbal Ahmed
CEO | Chief Executive Officer | - | 84-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 36.5 | 0.00% | 11,414 |
24-04-30 | 36.5 | 0.00% | 204,261 |
24-04-29 | 36.5 | 0.00% | 0 |
24-04-26 | 36.5 | 0.00% | 105,000 |
24-04-25 | 36.5 | 0.00% | 5,473 |
Delayed Quote London S.E., May 01, 2024 at 11:35 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |
- Stock Market
- Equities
- BXPHARMA Stock
- BXP Stock